Developer docs
API playgroundTry for free, no card

Search company profiles

Outset Medical

Full company profile

uuid0000pgh

Namestring
Outset Medical
Legal namestring
Outset Medical, Inc.
Company typeenum
Public
Founded yearint
2003
Descriptiontext

Outset Medical is a publicly traded medical technology company (NASDAQ: OM) that designs and sells the Tablo Hemodialysis System, an integrated dialysis platform targeting acute and home dialysis settings for U.S. hospitals, health systems, skilled nursing facilities, and end-stage kidney disease patients. Tablo combines on-site water purification, on-demand dialysate generation, a touchscreen-guided user interface, sensor-based automation, a single-use pre-assembled cartridge, and two-way cloud connectivity in a single enterprise device, covering roughly 95 percent of hospital dialysis treatments including ICU, PIRRT, and SLED without requiring a dedicated water room. The next-generation platform received FDA 510(k) clearance incorporating the agency's June 2025 cybersecurity guidance and is the first hemodialysis system to do so.

The company's revenue model combines hardware sales of the Tablo device with recurring service and support contracts, recurring single-use cartridge and accessory consumables, and ancillary services such as clinical training, the Bridge Program for transitional staffing during insourcing, and the Destination Home home-program launch offering. Go-to-market is a direct enterprise field-sales motion targeting hospital administrators, nephrologists, and nursing leadership, supplemented by a patient-facing channel for home hemodialysis and a partnership with US Renal Care. Outset serves nearly 1,000 U.S. hospitals and health systems, including all eight of the largest U.S. national health systems, and reported $119.5 million in full-year 2025 revenue with non-GAAP gross margin of 39.6 percent and operating cash burn reduced to $46 million from $116 million in 2024. The company is headquartered in San Jose, California, manufactures in North America, and employs 251 to 500 people.

Short descriptiontext

Outset Medical is a NASDAQ-listed medical technology company that sells the Tablo Hemodialysis System to U.S. hospitals, health systems, skilled nursing facilities, and home dialysis patients, combining integrated water purification, sensor-based automation, and cloud-connected EMR integration in a single device.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSan Jose, United States
HQ citystring
San Jose
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
hemodialysis systems, dialysis equipment, water purification, medical devices, renal care
Industry3 codes
PRIMARYHLAHAKAA
Hemodialysis Machines & Systems
SECONDARYHLAHAKAG
Home Dialysis Equipment & Remote Monitoring
SECONDARYHLAHAKAD
Dialysis Water Treatment & Dialysate Delivery Systems
NAICS code1 code
  • Kidney Dialysis Centers621492
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Hemodialysis Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Tablo Hemodialysis System Hardware Sales
TypeHardware Sales
Description

Outset Medical generates revenue primarily from selling the Tablo dialysis system hardware to hospitals, healthcare systems, skilled nursing facilities, and home dialysis programs. The system is sold as a capital device with various purchase and service agreement options.

finance.yahoo.com
2Service and Support Contracts
TypeSubscription Recurring
Description

Annual service agreements covering technical support, software updates, preventive maintenance, and field service. Agreements may include planned maintenance, on-site support, phone support, and biomed training through the Partnership program.

outsetmedical.com
3Consumables and Accessories
TypeUsage Based
Description

Revenue from single-use Tablo cartridges and accessories used with each treatment. The cartridge is pre-assembled and replaced per treatment.

finance.yahoo.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Tablo
Description

Tablo Hemodialysis System - a first-of-its-kind dialysis system designed for acute and home dialysis care.

outsetmedical.com
+5 more records
Core offering1 text field

Outset Medical designs, manufactures, and sells the Tablo Hemodialysis System — a single, all-in-one console that integrates water purification, on-demand dialysate generation, and treatment delivery with a guided touchscreen interface and cloud connectivity. The platform is deployed in acute care hospitals, skilled nursing facilities, and patient homes for both in-center and home hemodialysis, supported by recurring single-use Tablo cartridge consumables and data/subscription services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 94% reduction in serious cardiac or respiratory events over 5 years at AdventHealth
+9 more records
Product overview1 text field

Outset Medical offers a unified product ecosystem centered on the Tablo Hemodialysis System, a first-of-its-kind dialysis device covering 95% of acute and home dialysis treatments. The ecosystem includes TabloCart (mobile accessory), TabloHub (provider data/portal platform), and MyTablo (patient portal). EMR Connect enables integration with major EMR platforms like Epic, Cerner/Oracle Health, Meditech, and Gaia via HL7v2 or API/JSON. The company also provides comprehensive support services including Clinical Training, Technical Service, Bridge Program (temporary staffing), Destination Home (home program launch), Discover Dialysis (education), and Vascular Access Program.

Product and service7 records
1Tablo Hemodialysis System
CategoryHemodialysis equipment
Description

All-in-one hemodialysis machine with integrated water purification, on-demand dialysate generation, touchscreen-guided operation, and cloud connectivity, used in acute care hospitals, skilled nursing facilities, and home hemodialysis for end-stage renal disease patients.

2Tablo Cartridge
CategoryDialysis consumables
Description

Single-use disposable cartridge consumable used with the Tablo Hemodialysis System for each dialysis treatment, generating recurring revenue per treatment.

3TabloCart
CategoryDialysis accessories
Description

Mobile cart accessory that allows the Tablo Hemodialysis System console to be transported easily within a hospital, clinic, or care facility.

4TabloHub
CategoryConnected health software
Description

Cloud-based data and clinical workflow platform that aggregates treatment data from Tablo consoles for monitoring, analytics, and operational reporting by healthcare providers.

5MyTablo
CategoryPatient-facing software
Description

Patient-facing mobile application for individuals performing home hemodialysis with Tablo, supporting treatment setup, progress tracking, education, and communication with care teams.

6EMR Connect
CategoryHealthcare interoperability software
Description

Integration solution that connects the Tablo system and TabloHub to hospital electronic medical record (EMR) systems, automating documentation and clinical data exchange.

7Tablo Service and Support Plans
CategoryService and support
Description

Post-sale service, maintenance, training, and technical support agreements for healthcare providers operating the Tablo Hemodialysis System.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-01
Description

US Renal Care partnered with Outset Medical to offer patients accessible and easy-to-use home dialysis tools through the Tablo system. The partnership was specifically mentioned as helping fuel home dialysis participation growth and expanding patient access to home hemodialysis options.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

World's largest dialysis products and services company, manufacturing hemodialysis machines (e.g., 2008T) and operating the largest U.S. dialysis clinic network. Competes head-on with Outset across acute care, home dialysis, and consumables, but with a vastly broader product portfolio and entrenched service relationships.

TypeBroad incumbent
Description

Leading U.S. dialysis services provider that also supplies equipment and home dialysis programs. While primarily a services company, DaVita competes with Outset's hospital insourcing narrative because hospitals insource to reduce dependence on DaVita/Fresenius outsource contracts.

TypeBroad incumbent
Description

Major medical device manufacturer offering hemodialysis systems (e.g., AK 98) and PD solutions used in hospitals and clinics. Baxter is a direct equipment competitor to Tablo in acute and chronic hemodialysis settings, with established hospital procurement relationships.

TypeDirect peer
Description

UK-based developer of the SC+ hemodialysis system, a compact, easy-to-use device designed for both clinical and home use—directly mirroring Tablo's positioning. Competes head-to-head with Outset in portable/streamlined hemodialysis.

TypeDirect peer
Description

Pioneer in home hemodialysis with the System One, now owned by Fresenius. Targets the same home and acute dialysis markets as Outset, with comparable positioning around portability and patient independence.

6B. Braun Avitum
TypeBroad incumbent
Description

Dialysis products division of B. Braun manufacturing hemodialysis machines and disposables. Competes with Tablo in hospital and clinic settings across Europe and the U.S., with broader medical device portfolio.

TypeRegional player
Description

U.S. dialysis services provider and Outset's home dialysis partner. While not a direct equipment competitor, it is a relevant comparable because it operates the home modality infrastructure through which Tablo reaches patients.

TypeRegional player
Description

Provider of on-site dialysis in skilled nursing facilities (SNFs). Competes with Outset's SNF channel and shares the SNF-dialysis thesis, though as a services operator rather than equipment maker.

TypeRegional player
Description

U.S. dialysis services provider offering in-center and home dialysis. Relevant comparable as a customer/channel partner for Tablo-equivalent home dialysis equipment and as a service-line competitor to hospital insourcing.

TypeOthers
Description

Large diversified medical device company with adjacent hospital capital equipment expertise and digital health integrations (analogous to Tablo's EMR Connect strategy). Relevant as a benchmark for medtech scale and as a potential strategic acquirer of connected-device franchises.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds14 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Outset Medical

Hemodialysis Equipmentoutsetmedical.com

Outset Medical is a NASDAQ-listed medical technology company that sells the Tablo Hemodialysis System to U.S. hospitals, health systems, skilled nursing facilities, and home dialysis patients, combining integrated water purification, sensor-based automation, and cloud-connected EMR integration in a single device.

What Outset Medical does

Outset Medical is a publicly traded medical technology company (NASDAQ: OM) that designs and sells the Tablo Hemodialysis System, an integrated dialysis platform targeting acute and home dialysis settings for U.S. hospitals, health systems, skilled nursing facilities, and end-stage kidney disease patients. Tablo combines on-site water purification, on-demand dialysate generation, a touchscreen-guided user interface, sensor-based automation, a single-use pre-assembled cartridge, and two-way cloud connectivity in a single enterprise device, covering roughly 95 percent of hospital dialysis treatments including ICU, PIRRT, and SLED without requiring a dedicated water room. The next-generation platform received FDA 510(k) clearance incorporating the agency's June 2025 cybersecurity guidance and is the first hemodialysis system to do so.

The company's revenue model combines hardware sales of the Tablo device with recurring service and support contracts, recurring single-use cartridge and accessory consumables, and ancillary services such as clinical training, the Bridge Program for transitional staffing during insourcing, and the Destination Home home-program launch offering. Go-to-market is a direct enterprise field-sales motion targeting hospital administrators, nephrologists, and nursing leadership, supplemented by a patient-facing channel for home hemodialysis and a partnership with US Renal Care. Outset serves nearly 1,000 U.S. hospitals and health systems, including all eight of the largest U.S. national health systems, and reported $119.5 million in full-year 2025 revenue with non-GAAP gross margin of 39.6 percent and operating cash burn reduced to $46 million from $116 million in 2024. The company is headquartered in San Jose, California, manufactures in North America, and employs 251 to 500 people.

Outset Medical firmographics

Firmographics
Name
Outset Medical
Legal name
Outset Medical, Inc.
Website
https://outsetmedical.com
Company type
Public
Founded year
2003
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Outset Medical is a NASDAQ-listed medical technology company that sells the Tablo Hemodialysis System to U.S. hospitals, health systems, skilled nursing facilities, and home dialysis patients, combining integrated water purification, sensor-based automation, and cloud-connected EMR integration in a single device.
Ownership category
akta.pro rank

Outset Medical industry classification

Industry
Product category
Hemodialysis Equipment
NAICS
Kidney Dialysis Centers (621492)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAKAA
Hemodialysis Machines & Systems
SECONDARYHLAHAKAG
Home Dialysis Equipment & Remote Monitoring
SECONDARYHLAHAKAD
Dialysis Water Treatment & Dialysate Delivery Systems

Keywords

  • Hemodialysis systems
  • Dialysis equipment
  • Water purification
  • Medical devices
  • Renal care

Where Outset Medical is headquartered

Location

Headquarters

HQ city
San Jose
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Outset Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Tablo Hemodialysis System Hardware Sales: Outset Medical generates revenue primarily from selling the Tablo dialysis system hardware to hospitals, healthcare systems, skilled nursing facilities, and home dialysis programs. The system is sold as a capital device with various purchase and service agreement options.
  2. Service and Support Contracts: Annual service agreements covering technical support, software updates, preventive maintenance, and field service. Agreements may include planned maintenance, on-site support, phone support, and biomed training through the Partnership program.
  3. Consumables and Accessories: Revenue from single-use Tablo cartridges and accessories used with each treatment. The cartridge is pre-assembled and replaced per treatment.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Outset Medical product offering

Product offering

Core offering

Outset Medical designs, manufactures, and sells the Tablo Hemodialysis System — a single, all-in-one console that integrates water purification, on-demand dialysate generation, and treatment delivery with a guided touchscreen interface and cloud connectivity. The platform is deployed in acute care hospitals, skilled nursing facilities, and patient homes for both in-center and home hemodialysis, supported by recurring single-use Tablo cartridge consumables and data/subscription services.

Product overview

Outset Medical offers a unified product ecosystem centered on the Tablo Hemodialysis System, a first-of-its-kind dialysis device covering 95% of acute and home dialysis treatments. The ecosystem includes TabloCart (mobile accessory), TabloHub (provider data/portal platform), and MyTablo (patient portal). EMR Connect enables integration with major EMR platforms like Epic, Cerner/Oracle Health, Meditech, and Gaia via HL7v2 or API/JSON. The company also provides comprehensive support services including Clinical Training, Technical Service, Bridge Program (temporary staffing), Destination Home (home program launch), Discover Dialysis (education), and Vascular Access Program.

Differentiator

Problem solved

Functional benefit

Brands

  • Tablo: Tablo Hemodialysis System - a first-of-its-kind dialysis system designed for acute and home dialysis care.
  • TabloHub
  • MyTablo
  • TabloCart
  • Outset Connect
  • EMR Connect

Products and services

  • Tablo Hemodialysis System All-in-one hemodialysis machine with integrated water purification, on-demand dialysate generation, touchscreen-guided operation, and cloud connectivity, used in acute care hospitals, skilled nursing facilities, and home hemodialysis for end-stage renal disease patients.
  • Tablo Cartridge Single-use disposable cartridge consumable used with the Tablo Hemodialysis System for each dialysis treatment, generating recurring revenue per treatment.
  • TabloCart Mobile cart accessory that allows the Tablo Hemodialysis System console to be transported easily within a hospital, clinic, or care facility.
  • TabloHub Cloud-based data and clinical workflow platform that aggregates treatment data from Tablo consoles for monitoring, analytics, and operational reporting by healthcare providers.
  • MyTablo Patient-facing mobile application for individuals performing home hemodialysis with Tablo, supporting treatment setup, progress tracking, education, and communication with care teams.
  • EMR Connect Integration solution that connects the Tablo system and TabloHub to hospital electronic medical record (EMR) systems, automating documentation and clinical data exchange.
  • Tablo Service and Support Plans Post-sale service, maintenance, training, and technical support agreements for healthcare providers operating the Tablo Hemodialysis System.

Quantifiable outcome

  • 94% reduction in serious cardiac or respiratory events over 5 years at AdventHealth
  • +9 more outcomes

Companies that use Outset Medical

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Outset Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature8 records

Outset Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • US Renal CarecoreStrategic or Co-development Partner · 1 July 2024US Renal Care partnered with Outset Medical to offer patients accessible and easy-to-use home dialysis tools through the Tablo system. The partnership was specifically mentioned as helping fuel home dialysis participation growth and expanding patient access to home hemodialysis options.

Scale indicators14 records

Recent moves6 records

Expansion highlights5 records

Outset Medical competitors and assessment

Company assessment

Broad incumbents

  • Fresenius Medical Care: World's largest dialysis products and services company, manufacturing hemodialysis machines (e.g., 2008T) and operating the largest U.S. dialysis clinic network. Competes head-on with Outset across acute care, home dialysis, and consumables, but with a vastly broader product portfolio and entrenched service relationships.
  • DaVita: Leading U.S. dialysis services provider that also supplies equipment and home dialysis programs. While primarily a services company, DaVita competes with Outset's hospital insourcing narrative because hospitals insource to reduce dependence on DaVita/Fresenius outsource contracts.
  • Baxter International: Major medical device manufacturer offering hemodialysis systems (e.g., AK 98) and PD solutions used in hospitals and clinics. Baxter is a direct equipment competitor to Tablo in acute and chronic hemodialysis settings, with established hospital procurement relationships.
  • B. Braun Avitum: Dialysis products division of B. Braun manufacturing hemodialysis machines and disposables. Competes with Tablo in hospital and clinic settings across Europe and the U.S., with broader medical device portfolio.

Direct peers

  • Quanta Dialysis Technologies: UK-based developer of the SC+ hemodialysis system, a compact, easy-to-use device designed for both clinical and home use—directly mirroring Tablo's positioning. Competes head-to-head with Outset in portable/streamlined hemodialysis.
  • NxStage Medical (Fresenius): Pioneer in home hemodialysis with the System One, now owned by Fresenius. Targets the same home and acute dialysis markets as Outset, with comparable positioning around portability and patient independence.

Regional players

  • U.S. Renal Care: U.S. dialysis services provider and Outset's home dialysis partner. While not a direct equipment competitor, it is a relevant comparable because it operates the home modality infrastructure through which Tablo reaches patients.
  • Dialyze Direct: Provider of on-site dialysis in skilled nursing facilities (SNFs). Competes with Outset's SNF channel and shares the SNF-dialysis thesis, though as a services operator rather than equipment maker.
  • Innovative Renal Care (formerly American Renal Associates): U.S. dialysis services provider offering in-center and home dialysis. Relevant comparable as a customer/channel partner for Tablo-equivalent home dialysis equipment and as a service-line competitor to hospital insourcing.

Others

  • Medtronic: Large diversified medical device company with adjacent hospital capital equipment expertise and digital health integrations (analogous to Tablo's EMR Connect strategy). Relevant as a benchmark for medtech scale and as a potential strategic acquirer of connected-device franchises.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Outset Medical social profiles

Digital presence

Outset Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Outset Medical leadership team

Management profile

Number of profiles

Profiles4 records

Outset Medical funding detail

Funding detail

Funding overview

Funding rounds14 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Outset Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Outset Medical

What does Outset Medical do?

Outset Medical designs, manufactures, and sells the Tablo Hemodialysis System — a single, all-in-one console that integrates water purification, on-demand dialysate generation, and treatment delivery with a guided touchscreen interface and cloud connectivity. The platform is deployed in acute care hospitals, skilled nursing facilities, and patient homes for both in-center and home hemodialysis, supported by recurring single-use Tablo cartridge consumables and data/subscription services.

Is Outset Medical a public or private company?

Outset Medical is a public company. It is classified as public and is currently operating.

When was Outset Medical founded?

Outset Medical was founded in 2003. It employs 501 to 1,000 people.

Where is Outset Medical based?

Outset Medical is headquartered in San Jose, United States, in the North America region.

How does Outset Medical make money?

Three revenue lines are on record. Tablo Hemodialysis System Hardware Sales are the primary driver. The others are service and Support Contracts and consumables and Accessories.

Who are Outset Medical's main competitors?

Broad incumbents on record are Fresenius Medical Care, DaVita, Baxter International and B. Braun Avitum. Direct peers are Quanta Dialysis Technologies and NxStage Medical (Fresenius). Regional players are U.S. Renal Care, Dialyze Direct and Innovative Renal Care (formerly American Renal Associates). Medtronic is listed as an others.

Does Outset Medical have an API?

Yes. Tablo's EMR Connect supports HL7v2 and API/JSON communication options for secure, cloud-based two-way data transfer. The system transmits 70+ treatment fields, real-time updates, and event-based alerts from Tablo to compatible EMR platforms. This enables automated patient charting and documentation workflows.

What industry is Outset Medical in?

Outset Medical's product category is Hemodialysis Equipment. Its primary akta.pro industry code is HLAHAKAA, Hemodialysis Machines & Systems, with a secondary code of HLAHAKAG, Home Dialysis Equipment & Remote Monitoring. Its NAICS code is 621492 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketBeatOutset Medical Q3 Earnings Call HighlightsOutset Medical reported Q3 2026 revenue of $33.6 million, up 14% year-over-year, and reiterated full-year revenue guidance of $125 million to $130 million. Console revenue rose 26% to $10.5 million, and non-GAAP gross margin improved to 40.8%. The company expects to return to double-digit growth.YahooOutset Medical, Inc. (OM) Reports Q3 Loss, Tops Revenue EstimatesOutset Medical reported a Q3 loss of $0.68 per share, missing the consensus loss of $0.64, while revenues of $33.6 million beat the consensus by 6.65%. The company has topped revenue estimates twice in four quarters, but shares are expected to move in line with the market.MarketBeatOutset Medical, Inc. (NASDAQ:OM) Stock Has Consensus Price Target of $10.00Outset Medical shares opened at $4.08 with a consensus price target of $10.00 and a Hold rating from five analysts. The company reported Q2 EPS of -$0.80, missing the -$0.72 consensus, while revenue of $31.64 million beat expectations. Analysts forecast a fiscal-year EPS of -$3.81.American Banking and Market NewsReviewing Outset Medical (NASDAQ:OM) and Femasys (NASDAQ:FEMY)Femasys and Outset Medical are compared on institutional ownership, profitability, and analyst ratings. Femasys has higher institutional ownership (65.3% vs 2.5% insiders) and a stronger consensus rating, with a $50 target price versus $10 for Outset Medical. Femasys beats Outset Medical on 8 of 13 factors.Markets DailyOutset Medical, Inc. (NASDAQ:OM) Stock Has Consensus Target Price of $10.00 According to AnalystsOutset Medical shares have an average analyst rating of "Hold" with a $10.00 price target. The company reported Q2 EPS of -$0.80, missing the -$0.72 consensus, while revenue of $31.64 million beat the $28.97 million estimate. Analysts forecast a current-year EPS of -$3.81.AInvestOutset Medical's General Counsel Leaves Three Months After Its Operations Chief — What the Pattern MeansOutset Medical announced on Tuesday that General Counsel John Brottem, who joined in June 2020, is leaving, following R&D and Operations Chief Marc Nash's departure in June under similar boilerplate language. No successors were named in SEC filings. The stock fell about 75% from its 52-week high to $3.94, with $151 million in cash and roughly $45 million annual burn.Markets DailyOutset Medical (NASDAQ:OM) CEO Leslie Trigg Sells 3,437 Shares of StockOutset Medical CEO Leslie Trigg sold 3,437 shares of company stock on August 17 to cover tax withholding obligations related to equity vesting. The transaction reduced her direct ownership stake by 1.74%, leaving her with 194,597 shares valued at approximately $854,280.Investing.comOutset Medical general counsel sells $11,554 in stock By Investing.comJohn L. Brottem, General Counsel at Outset Medical, sold 2,632 shares for $11,554 to cover tax withholding obligations on vested Restricted Stock Units. This transaction follows the company's second quarter 2026 results, which showed revenue of $31.6 million beating estimates but a wider-than-expected adjusted loss per share.Markets DailyOutset Medical (NASDAQ:OM) CFO Renee Gaeta Sells 4,543 Shares of StockOutset Medical CFO Renee Gaeta sold 4,543 shares of company stock on August 17 to cover tax withholding obligations related to equity vesting. This transaction reduced her ownership stake by 2.45%, with the sale disclosed via a Securities and Exchange Commission filing.Markets DailyOutset Medical (NASDAQ:OM) Rating Increased to Hold at Wall Street ZenWall Street Zen upgraded its rating on Outset Medical from a sell to a hold in a research note issued on Saturday. The company recently reported quarterly earnings that missed analyst estimates for EPS, although revenue exceeded expectations. Institutional investors such as BNP Paribas Financial Markets and Legal & General Group Plc adjusted their holdings in the second quarter.